More Cyclopharm Limited news
Cyclopharm LimitedASX: CYC

US Clinical Paper - Technegas for Lung Transplant Evaluation

Dec 8, 2024 at 10:21 PM EST · Issued by Cyclopharm Limited

Filed with ASX · Dec 8, 2024 at 10:21 PM EST

On 6ix: 6ix.com/news/us-clinical-paper-technegas-for-lung-transplant-evaluation

Cyclopharm Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Cyclopharm Limited on 6ix

Story so far

  • First Patients Imaged with Technegas - French Clinical TrialDec 3, 2024
  • CYC Receives First Technegas Orders from US VA HospitalsNov 27, 2024
  • USA Reimbursement Update for TECHNEGASJun 24, 2024

Earlier from Cyclopharm

  • First Patients Imaged with Technegas - French Clinical TrialDec 2, 2024
  • CYC Receives First Technegas Orders from US VA HospitalsNov 27, 2024
  • CYC Signs Agreement with VA and First DoD Order ReceivedOct 3, 2024
  • Cyclopharm - 2024 First Half Results & USA Expansion UpdateSep 2, 2024
  • Cyclopharm 2024 H1 Trading and USA Expansion UpdateAug 26, 2024

Later from Cyclopharm

  • Cyclopharm's USA Technegas Expansion UpdateDec 20, 2024
  • Response to ASX Price QueryJan 6, 2025
  • CYC Signs US National Agreement with HCA for TechnegasJan 22, 2025
  • CYC Results SummaryFeb 24, 2025
  • CYC signs 5-year Agreement with USA Veterans AdministrationMar 13, 2025
All Cyclopharm news releases↗

Follow Cyclopharm into a list and get an email when it puts out news.

Follow Cyclopharm
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer